Daily profile of circulating C-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects: Relationship with renal function

References

• Trevisani F, Bernardi M, De Palma R, Pancione L, Capani F, Baraldini M, et al. Circadian variation in renal sodium and potassium handling in cirrhosis. The role of aldosterone, cortisol, sympathoadrenergic tone, and intratubular factors. Gastroenterology 1989; 96: 1187–98
   PubMedGoogle Scholar
• Bernardi M, Di Marco C, Trevisani F, Fornale L, Andreone P, Cursaro C, et al. Renal sodium retention during upright posture in preascitic cirrhosis. Gastroenterology 1993; 105: 188–93
   PubMed Web of Science ®Google Scholar
• Sansoe G, Ferrari A, Baraldi E, Castellana CN, De Santis MC, Manenti F. Renal distal tubular handling of sodium in central fluid volume homoeostasis in preascitic cirrhosis. Gut 1999; 45: 750–5
   PubMed Web of Science ®Google Scholar
• Wong F, Liu P, Tobe S, Morali G, Blendis L. Central blood volume in cirrhosis: measurement with radionuclide angiography. Hepatology 1994; 19: 312–21
   PubMedGoogle Scholar
• Wong F, Liu P, Allidina Y, Blendis L. Pattern of sodium handling and its consequences in patients with preascitic cirrhosis. Gastroenterology 1995; 108: 1820–7
   PubMedGoogle Scholar
• Bernardi M, Li Bassi S, Arienti V, De Collibus C, Scialpi C, Boriani L, et al. Systemic and regional hemodynamics in pre-ascitic cirrhosis: effects of posture. J Hepatol 2003; 39: 502–8
   PubMed Web of Science ®Google Scholar
• Claria J, Rodes J. Renal sodium handling in pre-ascitic cirrhosis. Gut 1999; 45: 639
   PubMedGoogle Scholar
• Wood LJ, Massie D, McLean AJ, Dudley FJ. Renal sodium retention in cirrhosis: tubular site and relation to hepatic dysfunction. Hepatology 1988; 8: 831–6
   PubMedGoogle Scholar
• Wong F, Liu P, Blendis L. Sodium homeostasis with chronic sodium loading in preascitic cirrhosis. Gut 2001; 49: 847–51
   PubMed Web of Science ®Google Scholar
• Bernardi M, Trevisani F, Santini C, De Palma R, Gasbarrini G. Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation. Gut 1983; 24: 761–6
   PubMed Web of Science ®Google Scholar
• Girgrah N, Liu P, Collier J, Blendis L, Wong F. Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis. Gut 2000; 46: 114–20
   PubMedGoogle Scholar
• Trevisani F, Bernardi M, Gasbarrini A, Tame MR, Giancane S, Andreone P, et al. Bed-rest-induced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintain “compensation”?. J Hepatol 1992; 16: 190–6
   PubMedGoogle Scholar
• Gerbes AL, Wernze H, Arendt RM, Riedel A, Sauerbruch T, Paumgartner G. Atrial natriuretic factor and renin-aldosterone in volume regulation of patients with cirrhosis. Hepatology 1989; 9: 417–22
   PubMed Web of Science ®Google Scholar
• Wong F, Sniderman K, Blendis L. The renal sympathetic and renin-angiotensin response to lower body negative pressure in well-compensated cirrhosis. Gastroenterology 1998; 115: 397–405
   PubMed Web of Science ®Google Scholar
• Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990; 168: 863–70
   PubMed Web of Science ®Google Scholar
• Komatsu Y, Nakao K, Suga S, Ogawa Y, Mukoyama M, Arai H, et al. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology 1991; 129: 1104–6
   PubMed Web of Science ®Google Scholar
• Kaneko T, Shirakami G, Nakao K, Nagata I, Nakagawa O, Hama N, et al. C-type natriuretic peptide (CNP) is the major natriuretic peptide in human cerebrospinal fluid. Brain Res 1993; 612: 104–9
   PubMedGoogle Scholar
• Mattingly MT, Brandt RR, Heublein DM, Wei CM, Nir A, Burnett JC, Jr. Presence of C-type natriuretic peptide in human kidney and urine. Kidney Int 1994; 46: 744–7
   PubMedGoogle Scholar
• Stingo AJ, Clavell AL, Heublein DM, Wei CM, Pittelkow MR, Burnett JC, Jr. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol 1992; 263: H1318–21
   PubMed Web of Science ®Google Scholar
• Stingo AJ, Clavell AL, Aarhus LL, Burnett JC, Jr. Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol 1992; 262: H308–12
   PubMed Web of Science ®Google Scholar
• Wei CM, Heublein DM, Perrella MA, Lerman A, Rodeheffer RJ, McGregor CG, et al. Natriuretic peptide system in human heart failure. Circulation 1993; 88: 1004–9
   PubMed Web of Science ®Google Scholar
• Hama N, Itoh H, Shirakami G, Suga S, Komatsu Y, Yoshimasa T, et al. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem Biophys Res Commun 1994; 198: 1177–82
   PubMed Web of Science ®Google Scholar
• Cargill RI, Barr CS, Coutie WJ, Struthers AD, Lipworth BJ. C-type natriuretic peptide levels in cor pulmonale and in congestive heart failure. Thorax 1994; 49: 1247–9
   PubMedGoogle Scholar
• Igaki T, Itoh H, Suga S, Hama N, Ogawa Y, Komatsu Y, et al. C-type natriuretic peptide in chronic renal failure and its action in humans. Kidney Int 1996; Suppl 55: S144–7
   Google Scholar
• Barletta G, Lazzeri C, Vecchiarino S, Del Bene R, Messeri G, Dello Sbarba A, et al. Low-dose C-type natriuretic peptide does not affect cardiac and renal function in humans. Hypertension 1998; 31: 802–8
   PubMed Web of Science ®Google Scholar
• Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, et al. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 1991; 252: 120–3
   PubMed Web of Science ®Google Scholar
• Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992; 130: 229–39
   PubMed Web of Science ®Google Scholar
• Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321–8
   PubMed Web of Science ®Google Scholar
• Wei CM, Aarhus LL, Miller VM, Burnett JC, Jr. Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol 1993; 264: H71–3
   PubMed Web of Science ®Google Scholar
• Clavell AL, Stingo AJ, Wei CM, Heublein DM, Burnett JC, Jr. C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol 1993; 264: R290–5
   PubMed Web of Science ®Google Scholar
• Charles CJ, Espiner EA, Richards AM, Nicholls MG, Yandle TG. Biological actions and pharmacokinetics of C-type natriuretic peptide in conscious sheep. Am J Physiol 1995; 268: R201–7
   Google Scholar
• Komeichi H, Moreau R, Cailmail S, Gaudin C, Lebrec D. Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis. J Hepatol 1995; 22: 319–25
   PubMedGoogle Scholar
• Hunt PJ, Richards AM, Espiner EA, Nicholls MG, Yandle TG. Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab 1994; 78: 1428–35
   PubMedGoogle Scholar
• Cargill RI, Struthers AD, Lipworth BJ. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II. Cardiovasc Res 1995; 29: 108–11
   PubMedGoogle Scholar
• Bernardi M, Di Marco C, Trevisani F, De Collibus C, Fornale L, Baraldini M, et al. The hemodynamic status of preascitic cirrhosis: an evaluation under steady-state conditions and after postural change. Hepatology 1992; 16: 341–6
   PubMed Web of Science ®Google Scholar
• Gulberg V, Moller S, Henriksen JH, Gerbes AL. Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure. Gut 2000; 47: 852–7
   PubMed Web of Science ®Google Scholar
• Bernardi M, De Palma R, Trevisani F, Santini C, Capani F, Baraldini M, et al. Chronobiological study on factors affecting plasma aldosterone concentration in cirrhosis. Gastroenterology 1986; 91: 683–91
   PubMed Web of Science ®Google Scholar
• Bernardi M, Trevisani F, De Palma R, Ligabue A, Capani F, Baraldini M, et al. Chronobiological evaluation of sympathoadrenergic function in cirrhosis. Relationship with arterial pressure and heart rate. Gastroenterology 1987; 93: 1178–86
   PubMedGoogle Scholar